David Jesse Sanchez

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting Viral RNA-Dependent RNA Polymerases as an Antiviral Therapy”.

Targeting Viral RNA-Dependent RNA Polymerases as an Antiviral Therapy

Current Medicinal Chemistry(2021)10.2174/0929867328666210204205726

N/A

0DataRank · unranked

2 citations

David Jesse Sanchez, Daniel Reyes Miranda

Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis

Molecular and Cellular Biochemistry(2022)10.1007/s11010-021-04321-z

N/A

0DataRank · unranked

8 citations

David Jesse Sanchez, Devendra K. Agrawal, Finosh G. Thankam

Fragile X Messenger Ribonucleoprotein 1 (FMR1), a novel inhibitor of osteoblast/osteocyte differentiation, regulates bone formation, mass, and strength in young and aged male and female mice

Bone Research(2023)10.1038/s41413-023-00256-x

N/A

0DataRank · unranked

5 citations

Julián Balanta‐Melo, Amy Creecy, Chongshan Liu, Alejandro Marcial, Laura Morales +10 more

Lentivirus Transduced T Cell Lines Response to Pro-Inflammatory and Antiviral Cytokines in the Presence of HIV

Journal of Biosciences and Medicines(2024)10.4236/jbm.2024.1210019

N/A

0DataRank · unranked

0 citations

Daniel Reyes Miranda, David Jesse Sanchez, Kevin Ventocilla

Kaposi’s Sarcoma-Associated Herpesvirus targeting of CD1c by the K8.1 glycoprotein 4107

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1828

N/A

0DataRank · unranked

0 citations

David Jesse Sanchez, R. Alarcó Hernández